Parkinsonism in patients with chronic hepatitis C treated with interferon-α2b: a report of two cases

被引：8
|
作者：
Kajihara, Mikio [1 ]
Montagnese, Sara [1 ,3 ]
Khanna, Pooja [1 ]
Amodio, Piero [3 ]
Schapira, Anthony H. V. [2 ]
Dusheiko, Geoffrey M. [1 ]
Morgan, Marsha Y. [1 ]
机构：
[1] UCL, Ctr Hepatol, Dept Med, Sch Med, London NW3 2PF, England
[2] UCL, Univ Dept Clin Neurosci, Univ Coll London Med Sch, London NW3 2PF, England
[3] Univ Padua, Clin Med V, Dept Clin & Expt Med, I-35100 Padua, Italy
来源：
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY | 2010年 / 22卷 / 05期
关键词：
hepatitis C virus; interferon; Parkinsonism; DRUG-INDUCED PARKINSONISM; TUMOR-NECROSIS-FACTOR; ALPHA; THERAPY; PEGINTERFERON; PERSISTENT; RIBAVIRIN;
D O I：
10.1097/MEG.0b013e32833383e3
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Details of two patients with chronic hepatitis C infection who developed features of Parkinsonism when treated with IFN-alpha 2b and ribavirin are reported. The symptoms resolved when treatment was discontinued in one patient but not in the other. Physicians should be alert to the possibility that drug-related Parkinsonism may complicate treatment of hepatitis C infection with antiviral agents; the agent most likely responsible is IFN-alpha 2b. Prompt withdrawal of treatment is mandatory but does not always guarantee reversal of the Parkinsonian features. Eur J Gastroenterol Hepatol 22:628-631 (C) 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins.
引用
收藏
页码：628 / 631
页数：4
相关论文
共 50 条
  • [21] Combination Therapy with Interferon-α2b, Ribavirin, and Amantadine in Chronic Hepatitis C Nonresponders to Interferon and Ribavirin
    Paul J. Thuluvath
    Hemant Pande
    Joyce Maygers
    Digestive Diseases and Sciences, 2003, 48 : 594 - 597
  • [22] Combination therapy with interferon-α2b, ribavirin, and amantadine in chronic hepatitis C nonresponders to interferon and ribavirin
    Thuluvath, PJ
    Pande, H
    Maygers, J
    DIGESTIVE DISEASES AND SCIENCES, 2003, 48 (03) : 594 - 597
  • [23] Interleukin-2 Plus Ribavirin Versus Interferon-α-2b Plus Ribavirin in Patients with Chronic Hepatitis C Who Did Not Respond to Previous Interferon-α-2b Treatment
    Mariano Malaguarnera
    Giovanni Pistone
    Sergio Neri
    Marcello Romano
    Alfio Brogna
    Salvatore Musumeci
    BioDrugs, 2004, 18 : 407 - 413
  • [24] Interleukin-2 plus ribavirin versus interferon-α-2b plus ribavirin in patients with chronic hepatitis C who did not respond to previous interferon-α-2b treatment
    Malaguarnera, M
    Pistone, G
    Neri, S
    Romano, M
    Brogna, A
    Musumeci, S
    BIODRUGS, 2004, 18 (06) : 407 - 413
  • [25] Case Report: Granulomatous Hepatitis in a Patient with Chronic Hepatitis C Treated with Interferon-α
    Manjakkollai P. Veerabagu
    Sydney D. Finkelstein
    Mordechai Rabinovitz
    Digestive Diseases and Sciences, 1997, 42 : 1445 - 1448
  • [26] Lipoprotein changes in patients with chronic hepatitis C treated with interferon-α
    Fernández-Miranda, C
    Castellano, G
    Guijarro, C
    Fernández, I
    Schöebel, N
    Larumbe, S
    Gómez-Izquierdo, T
    del Palacio, A
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 1998, 93 (10): : 1901 - 1904
  • [27] Fluoxetine Disposition in Patients with Chronic Hepatitis C Treated with Interferon-α
    Furlanut, Mario
    Soardo, Giorgio
    Donnini, Debora
    Sechi, Leonardo
    Franceschi, Loretta
    CLINICAL PHARMACOKINETICS, 2010, 49 (11) : 767 - 772
  • [28] Fluoxetine Disposition in Patients with Chronic Hepatitis C Treated with Interferon-α
    Mario Furlanut
    Giorgio Soardo
    Debora Donnini
    Leonardo Sechi
    Loretta Franceschi
    Clinical Pharmacokinetics, 2010, 49 : 767 - 772
  • [29] Psychiatric symptoms induced by antiviral therapy in chronic hepatitis C -: Comparison between interferon-α-2a and interferon-α-2b
    Neri, Sergio
    Pulvirenti, Davide
    Bertino, Gaetano
    CLINICAL DRUG INVESTIGATION, 2006, 26 (11) : 655 - 662
  • [30] Continuous interferon-α2b infusion in combination with ribavirin for chronic hepatitis C in treatment-experienced patients
    Roomer, Robert
    Bergmann, Jilling F.
    Boonstra, Andre
    Hansen, Bettina E.
    Haagmans, Bart L.
    Kwadijk-de Gijsel, Sonja
    van Vuuren, Anneke J.
    de Knegt, Robert J.
    Janssen, Harry L. A.
    ANTIVIRAL THERAPY, 2012, 17 (03) : 509 - 517
12345